-
Recent Posts
Categories
- Adventure (3)
- Art (5)
- Crafts (1)
- Culture (8)
- FDA (2)
- Health policy (10)
- JAMA (1)
- Legal (3)
- Medicine (12)
- Medscape (7)
- Music (1)
- New York Times (4)
- Science (7)
- Science magazine (1)
- Smithsonian.com (7)
- The Lancet (1)
- The New Scientist (1)
- The Washington Post (3)
- Travel (2)
- Wall Street Journal (1)
Social Media
Archives
Contact
Tag Archives: FDA
‘Nonsensical’ Limits on Supportive Drugs Complicate Cancer Care
November 13, 2024 A young woman with breast cancer was experiencing such intense hot flashes from her triplet chemotherapy regimen, AC-T, that she begged to stop treatment. Her oncologist, Ramy Sedhom, MD, suggested she take oxybutynin, an inexpensive drug for overactive … Continue reading
Posted in FDA, Medicine, Medscape
Tagged anti-nausea, cancer, cancer care, ethics, FDA, health insurance, medical ethics, odanesetron, oncology, pill limits, prior authorization
Leave a comment
Psychologists and Psychotropic Prescribing: An Old Debate Heats Up
December 13, 2024 Earlier this year, Utah became the seventh state to allow psychologists with the proper training to prescribe psychotropic medications, giving supporters reason to hope that more states might support expanding this scope of practice. However, the American … Continue reading
Posted in Health policy, Medicine, Medscape
Tagged antidepressants, FDA, Medscape Medical News, mental health, pharmacy, primary care, psychiatry, psychology, psychotropic drugs
Leave a comment
Should the FDA Reconsider Antidepressant Boxed Warnings?
December 23, 2024 For almost two decades, antidepressants have carried boxed warnings linking the medications to an increased risk for suicidal thoughts and behaviors in young people. Paradoxically, and for almost as long, evidence suggests these warnings may have led … Continue reading
Posted in FDA, Health policy, Medicine, Medscape
Tagged adolescents, antidepressants, FDA, Medscape Medical News, mental health, psychiatry, psychology, suicide
Leave a comment
Califf Breezes Through Nomination Hearing for FDA Chief
WASHINGTON — Most members of a Senate committee had few reservations yesterday about Robert Califf’s qualifications to be the next commissioner of the US Food and Drug Administration (FDA). “You come here today with impressive qualifications,” said Senate Health, Education, … Continue reading
Shifting Tactics in the Battle Against Influenza
When U.S. Food and Drug Administration experts met to pick viral targets for the next flu season, they also discussed a promising new way to create vaccines. Read more…